HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$4.23
Day range
$3.98 - $4.42
Year range
$1.35 - $9.65
Market cap
354.12M USD
Avg Volume
597.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.57M | 79.08% |
Operating expense | 33.10M | -10.16% |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | -0.22 | 96.33% |
EBITDA | -30.68M | 13.45% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | 2.06 | — |
Return on assets | — | — |
Return on capital | -38.38% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | 16.85M | 295.44% |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
143
